In addition to growth monitoring, recent research by Lauer JM et al. highlights the impact of SQ-LNS pediatric nutrition on child development. Specifically, the team conducted an 18-month trial in Lusaka, Zambia, to evaluate intestinal health. They investigated whether small-quantity lipid-based nutrient supplements (SQ-LNS) could reduce environmental enteric dysfunction (EED) and systemic inflammation. While experts know SQ-LNS improves growth and survival, the specific biological pathways remain unclear.

Potential of SQ-LNS Pediatric Nutrition Beyond Intestinal Health

During the trial, the study analyzed 302 children aged 27 to 35 months using serum biomarkers and rectal swabs. Moreover, researchers looked for changes in gut microbiome alpha diversity, beta diversity, and systemic inflammation. Furthermore, they measured markers such as intestinal fatty acid-binding protein (I-FABP) and C-reactive protein. However, the results showed no broad changes in intestinal health markers. Consequently, the supplement did not significantly alter the overall microbial community composition.

Therefore, these findings suggest that the clinical benefits of SQ-LNS likely come from increased nutrient availability. Although the study found a lower abundance of Enterococcus in the intervention group, it detected no other major shifts. As a result, this evidence implies that doctors should focus on nutritional density for growth outcomes. Ultimately, managing EED might require different environmental or clinical interventions beyond standard lipid-based supplements.

What is the role of SQ-LNS in child growth?

SQ-LNS provides essential micronutrients and a small caloric boost to prevent stunting and wasting in young children. While it supports linear growth, it may not directly resolve intestinal inflammation.

Does SQ-LNS improve gut microbiome diversity?

According to the Zambian study, 18 months of supplementation did not lead to significant changes in gut microbial diversity or overall community structure in children.

Which biomarkers were used to assess EED?

Researchers used the Multiple-Micronutrient and Environmental Enteric Dysfunction Assessment Tool (MEEDAT) to measure soluble CD14 and intestinal fatty acid-binding protein (I-FABP).

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider for any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Lauer JM et al. Gut Microbiome and Environmental Enteric Dysfunction Are Unchanged by 18 Months of Small-Quantity Lipid-Based Nutrient Supplementation among Young Children in Lusaka, Zambia. Br J Nutr. 2026 Jun 22. doi: 10.1017/S0007114526107818. PMID: 42324602.
2. Fink G et al. The impact of home-installed growth charts and small-quantity lipid-based nutrient supplements (SQ-LNS) on child growth in Zambia: a four-arm parallel open-label cluster randomised controlled trial. BMJ Glob Health. 2024;9(8):e015438.
3. Dewey KG et al. Small-quantity lipid-based nutrient supplements for the prevention of child undernutrition: a primary care-based intervention. Matern Child Nutr. 2021;17 Suppl 1:e13227.